Cymabay Therapeutics

1 follower

‌

CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to treat metabolic diseases, including serious rare and orphan diseases.

Industries

Pharmaceutical

Headquarters

Newark, United States

Employees

51-200

Links

Org chart

Klara Dickinson

Chief Regulatory and Quality Assurance Officer

Paul Quinlan

General Counsel and Secretary

Robert Martin

Senior Vice President, Manufacturing and Nonclinical Development

Robert L.

Senior Director Of Information Technology

Ken B.

Senior Vice President Human Resources

Bsn Mary Standen Rn

Vice President; Head Of Medical Affairs

Patricia Rohane

Vice President, Clinical Development

Theresa T Patton

Vice President Of Market Access

Tony Folck

Associate Director - HCP Marketing

Thomas Taylor

Associate Director, Commercial Business Systems Relations

Head, Commercial

Director, Accounting

Accounting Manager

Senior Manager, Financial Planning And Analysis

Akash Patnaik

Corporate Controller

Yun-Jung Choi

Senior Fellow Of Translational Medicine

Harleen Kaur

Senior Clinical Trial Manager

Liza Kim

Clinical Research Associate

Georgina Xanthou

Senior Medical Writer

Teams

Directors Team

10 members

Clinical and Medical Affairs

7 members

Leadership Team

2 members

Finance and Accounting

6 members

Regulatory and Quality Assurance Team

4 members

Clinical and Scientific Team

1 members

Similar companies

SmithRx

4 followers

Harrow

2 followers

Nutrafol

7 followers

Bristol-Myers Squibb

186 followers

Formation Bio

2 followers

Alnylam Pharmaceuticals

20 followers

NYU Langone Health

13 followers

Azurity Pharmaceuticals

3 followers

AbbVie

177 followers

PhRMA

1 follower

Royalty Pharma

1 follower

Explore companies